Skip to main content
. 2017 May 18;77(2):188–195. doi: 10.1136/annrheumdis-2017-211172

Table 5.

Primary and secondary outcomes at 24-month follow-up for the subgroup of patients with unstable meniscus tear. Values are means with 95% CIs and numbers (percentage)

APM (n=34) Placebo surgery (n=39) Improvement from baseline (or 24mo) Between-Group Difference in Improvement from Baseline or P value
Primary outcomes APM Placebo surgery
WOMET score 84.6 (78.0 to 91.3) 84.5 (78.9 to 90.0) 27.7 (19.5 to 35.9) 33.3 (27.5 to 39.1) −5.6 (−15.3 to 4.1)
Lysholm knee score 84.5 (78.7 to 90.3) 86.7 (83.2 to 90.3) 23.4 (16.7 to 30.2) 27.5 (22.6 to 32.4) −4.0 (−12.1 to 4.0)
Pain after exercise  2.2 (1.4 to 3.0)  2.2 (1.5 to 3.0)  3.5 (2.6 to 4.4)  4.1 (3.2 to 4.9) −0.6 (−1.8 to 0.6)
Secondary outcomes
Treatment-group unblinding  3 (8.8%)  3 (7.3%) p=1.000
Satisfied patients 26 (76.5%) 31 (79.5%) p=0.784
Improved patients 30 (88.2%) 35 (89.7%) p=1.000
Returned to normal activities 23 (67.6%) 30 (76.9%) p=0.436
Mechanical symptoms  8 (23.5) 10 (25.6) p=1.000
At least one positive meniscal test 10 (29.4) 13 (33.3) p=0.803

Two patients lost to follow-up, both in placebo-surgery group. p Values for interaction (randomisation and unstable tear) were 0.701, 0.754 and 0.623 for the change in WOMET score, Lysholm knee score and pain after exercise, respectively.

APM, arthroscopic partial meniscectomy; WOMET, Western Ontario Meniscal Evaluation Tool.